Latest Insights on CRSP
The #1 Breakthrough Biotech Stock for 2023CRISPR Therapeutics is dedicated to 2 things: genetics research and saving lives. find out why this biotech stock is our #1 pick for 2023!
Great Glimmers Of Positivity; Hyzon’s Prime Time Destiny
July 15, 2022 Great StuffFriday Feedback: The “Don’t Worry, Be Happy” Edition Here’s a little e-zine I wrote. You might want to read it note for note. Don’t worry. Be happy. In every market we have some trouble. But when you worry, your losses double. Don’t worry. Be happy. Great Ones, I have to thank you. Seriously. There’s no […]
CRISPR Capers, Hyzon Hot Takes & GOGO Wifi Rangers
October 8, 2021 Great StuffGenome What I’m Sayin’? At long last … the day has come! ‘Round here, Fridays are filled with Reader Feedback from start to finish — like a feast of meaty market morsels, delectable investing questions and awkward food analogies. It’s once again time to hold my nose and dive into the Great Stuff inbox to […]
Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance
June 28, 2021 Great StuffWall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]